Major drugmakers’ 1H profits slashed by cuts in drug prices

After the government forced down prices of medicines in April, the country’s leading pharmaceutical companies including top-tier ones have struggled to keep afloat in the first half of the year.

Despite increased sales by 6.9 percent on-year, market leaders like Dong-A Pharmaceutical, Daewoong Pharmaceutical, Yuhan Corporation and Hanmi Pharmaceutical saw profits almost halve, according to r...